Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity.
Gauthier, L., Morel, A., Anceriz, N., Rossi, B., Blanchard-Alvarez, A., Grondin, G., Trichard, S., Cesari, C., Sapet, M., Bosco, F., Rispaud-Blanc, H., Guillot, F., Cornen, S., Roussel, A., Amigues, B., Habif, G., Caraguel, F., Arrufat, S., Remark, R., Romagne, F., Morel, Y., Narni-Mancinelli, E., Vivier, E.(2019) Cell 177: 1701-1713.e16
- PubMed: 31155232 
- DOI: 10.1016/j.cell.2019.04.041
- Primary Citation of Related Structures:  
6IAP, 6IAS - PubMed Abstract: 
Over the last decade, various new therapies have been developed to promote anti-tumor immunity. Despite interesting clinical results in hematological malignancies, the development of bispecific killer-cell-engager antibody formats directed against tumor ...